논문KCI 등재
Contemporary trends in extrahepatic mortality of chronic liver disease in the United States from 2014 to 2023
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
관련 논문AI추천
Contemporary burden of mortality from chronic liver disease by sex and race/ethnicity in the United StatesAijaz Ahmed, Donghee Kim, George Cholankeril, Karn Wijarnpreecha, Pojsakorn Danpanichkul대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Rising drug overdose deaths in chronic liver disease in the United States, 2015–2023Aijaz Ahmed, Brittany B Dennis, Donghee Kim, George Cholankeril, Karn Wijarnpreecha, Pojsakorn Danpanichkul대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Changes in Hospital Admissions and Mortality for Complications of Cirrhosis: Implications for Clinicians and Health SystemsBernd E. Schnabl, Michael E. Matheny, Samuel B. Ho거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제1호Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”Jeayeon Park, Su Jong Yu대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호The growing burden of non-alcoholic fatty liver disease on mortalityJu-Yeon Cho, Won Sohn대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”Sisi Yang, Zhenxuan Ma대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (76건)
2025 KASL clinical practice guidelines for management of hepatitis CEun Sun Jang, Eun Ju Cho, Chang Hun Lee, Do Seon Song, Nae-Yun Heo, Jae Yoon Jeong, Jung Gil Park, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jungpp. 1-52Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangi tis: Letter to the editor on “Safety and efficacy of HK 660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”Yizi He, Haifeng He, Qi Liang, Yongzhi Xiepp. 1-3Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”Sisi Yang, Zhenxuan Mapp. 4-6Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Xiaodi Yang, Zhongqing Qian, Qiong Wang, Fuliang Chen, Xiaojing Wang, Deyan Chenpp. 7-9Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Xinyi Li, Sheng Zhengpp. 10-12